Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

被引:0
|
作者
Yong Du
Ignasi Carrio
Giuseppe De Vincentis
Stefano Fanti
Harun Ilhan
Caroline Mommsen
Egbert Nitzsche
Francis Sundram
Wouter Vogel
Wim Oyen
Val Lewington
机构
[1] The Royal Marsden NHS Foundation Trust,Department of Nuclear Medicine & PET/CT
[2] Hospital Sant Pau,undefined
[3] Policlinico Umberto I University Hospital Rome,undefined
[4] University Hospital Bologna,undefined
[5] Ludwig-Maximilians-University Hospital,undefined
[6] Praxis für diagnostische und therapeutische Nuklearmedizin Berlin,undefined
[7] Canton Hospital Aarau,undefined
[8] University Hospital Southampton NHS Foundation Trust,undefined
[9] The Netherlands Cancer Institute,undefined
[10] The Institute of Cancer Research,undefined
[11] Guy’s and St Thomas’ NHS Foundation Trust,undefined
关键词
Bone metastases; Castration-resistant prostate cancer; Nuclear medicine; Radium dichloride; Ra-223; Targeted alpha therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1671 / 1678
页数:7
相关论文
共 50 条
  • [41] Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    Buroni, Federica Eleonora
    Persico, Marco Giovanni
    Pasi, Francesca
    Lodola, Lorenzo
    Nano, Rosanna
    Aprile, Carlo
    [J]. ANTICANCER RESEARCH, 2016, 36 (11) : 5719 - 5730
  • [42] Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Michel L. Peters
    Claudine de Meijer
    Dirk Wyndaele
    Walter Noordzij
    Annemarie M. Leliveld-Kors
    Joan van den Bosch
    Pieter H. van den Berg
    Agni Baka
    Jennifer G. Gaultney
    [J]. Applied Health Economics and Health Policy, 2018, 16 : 145 - 145
  • [43] Radium-223 in metastatic castration-resistant prostate cancer: current status and future perspectives
    Wyndaele D.N.J.
    [J]. Tijdschrift voor Urologie, 2020, 10 (6-7) : 131 - 140
  • [44] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
    Nilsson, Sten
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
  • [45] Impact of treatment delay in Radium-223 Dichloride therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, M. O.
    Holm, S.
    Petersen, P. M.
    Daugaard, G.
    Mortensen, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
  • [46] Predictors for survival after radium-223 (R223) treatment for castration-resistant metastatic prostate cancer.
    Anderson, Eric
    Wong, William
    Mohammadi, Homan
    Daniels, Thomas Backus
    Tzou, Katherine S.
    Schild, Steven E.
    Keole, Sameer R.
    Choo, Richard
    Bryce, Alan H.
    Thai Huu Ho
    Quevedo, Fernando
    Vora, Sujay A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [48] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    [J]. TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
  • [49] High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Christensen, Bryce Raymon
    Barata, Pedro C.
    Ledet, Elisa M.
    Layton, Jodi L.
    Lewis, Brian E.
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 476 - 479
  • [50] Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Buzzacchino, Federica
    Pozzi, Chiara
    Ferrara, Carla
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Civitelli, Liana
    De Vincentis, Giuseppe
    Tomao, Silverio
    Bianco, Vincenzo
    [J]. ONCOLOGY LETTERS, 2019, 17 (02) : 1467 - 1476